Bumper Offer - Urjas oil Just @ Rs. 1
Sucrapil is a commercial drug that is prescribed in the form of Suspension. Primarily, it is used for the treatment of Peptic Ulcer. Sucrapil also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Sucrapil. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Sucrapil are Constipation. While these are the most often observed Sucrapil side effects, there are can be others also. These have been listed below. Such side effects of Sucrapil normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Sucrapil has a Unknown effect for pregnant women and Unknown effect on lactating mothers. Warnings related to Sucrapil's effects on the liver, heart and kidney, if any, have been listed below.
Sucrapil is contraindicated in people with pre-existing medical conditions like Diabetes as it can result in adverse effects. The section on Sucrapil contraindications lists all such conditions.
Besides this, Sucrapil may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Sucrapil, it is important to know that it is not safe while driving, and is not habit-forming.
Sucrapil is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Sucrapil is used -
Moderate
Mild
Common
Is the use of Sucrapil safe for pregnant women?
No research has been done to ascertain the safety of Sucrapil in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Sucrapil safe during breastfeeding?
In the absence of any scientific study about the side effects of Sucrapil in breastfeeding women, information on safety of Sucrapil is unavailable.
What is the effect of Sucrapil on the Kidneys?
Sucrapil may have mild side effects on the kidneys.
What is the effect of Sucrapil on the Liver?
Sucrapil is completely safe for the liver.
What is the effect of Sucrapil on the Heart?
Sucrapil is not harmful for the heart.
Sucrapil should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Sucrapil unless your doctor advises you to do so -
Is this Sucrapil habit forming or addictive?
Sucrapil is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Sucrapil you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Sucrapil should be used only after doctor's advice.
Is it able to treat mental disorders?
Sucrapil is unable to treat or cure mental disorders.
Interaction between Food and Sucrapil
Taking Sucrapil with food is safe.
Interaction between Alcohol and Sucrapil
Information about the interaction of Sucrapil and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155